Showing results (1451-1460 of 1,688) with videos related to
Sort By:
Pageof 169
American Journal of Human Genetics|July 29, 2008
Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex developmentJérôme Bonnefont, Sergey I Nikolaev, Anselme L Perrier, et al.Inflammatory Bowel Diseases|November 1, 2006
Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutaseWei Han, Annick Mercenier, Afifa Ait-Belgnaoui, et al.Annales Francaises D'Anesthesie Et De Reanimation|August 24, 2010
[How can we optimize medical orderings in intensive care unit (ICU)?]J-J Lehot, C Heuclin, J Neidecker, et al.The American Journal of Cardiology|May 10, 2011
Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study)Mélanie Côté, Amélie Cartier, Anne Q Reuwer, et al.Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 20, 2011
Correlation of dosimetric parameters obtained with the analytical anisotropic algorithm and toxicity of chest chemoradiation in lung carcinomaLysian Cartier, Pierre Auberdiac, Mustapha Khodri, et al.Clinical Genitourinary Cancer|April 14, 2021
Prognostic Risk Classification for Biochemical Relapse-Free Survival in Oligometastatic Recurrent Prostate Cancer Determined by Choline PETGwenaelle Gravis, Aurélie Autret, Morgane Guibert-Broudic, et al.Biochemical and Biophysical Research Communications|April 25, 1996
Rapid protein identification using N-terminal "sequence tag" and amino acid analysisM R Wilkins, K Ou, R D Appel, et al.Biochemistry|August 5, 1997
A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from Conus purpurascens venomK J Shon, M Grilley, R Jacobsen, et al.The Journal of Biological Chemistry|September 5, 1997
Differential targeting of nicotinic acetylcholine receptors by novel alphaA-conotoxinsR Jacobsen, D Yoshikami, M Ellison, et al.Journal of the American College of Cardiology|July 3, 2007
Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcomeEberhard Grube, Gerhard Schuler, Lutz Buellesfeld, et al.Pageof 169